In vivo biotransformation of 17α‐methyltestosterone in the horse revisited: identification of 17‐hydroxymethyl metabolites in equine urine by capillary gas chromatography/mass spectrometry
- 6 January 2003
- journal article
- research article
- Published by Wiley in Rapid Communications in Mass Spectrometry
- Vol. 17 (4), 320-329
- https://doi.org/10.1002/rcm.909
Abstract
The in vivo phase I biotransformation of 17α-methyltestosterone in the horse leads to the formation of a complex mixture of regio- and stereoisomeric C20O2, C20O3 and C20O4 metabolites, excreted in urine as glucuronide and sulphate phase II conjugates. The major pathways of in vivo metabolism are the reduction of the A-ring (di- and tetrahydro), epimerisation at C-17 and oxidations mainly at C-6 and C-16. Some phase I metabolites have been identified previously by positive ion electron ionisation capillary gas chromatography/mass spectrometry (GC/EI + MS) mainly from the characteristic fragmentation patterns of their methyloxime-trimethylsilyl ether (MO-TMS), enol-TMS or TMS ether derivatives. Following oral administration of 17α-methyltestosterone to two castrated thoroughbred male horses, the glucuronic acid conjugates excreted in post-administration urine samples were selectively hydrolysed by E. coli β-glucuronidase enzymes. Unconjugated metabolites and the steroid aglycones obtained after enzymatic deconjugation were isolated from urine by solid-phase extraction, derivatised as MO-TMS ethers and analysed by GC/EI + MS. In addition to some of the known metabolites previously identified from the characteristic mass spectral fragmentation patterns of 17α-methyl steroids, some isobaric compounds exhibiting a diagnostic loss of 103 mass units from the molecular ions with subsequent losses of trimethylsilanol or methoxy groups and an absence of the classical D-ring fragment ion were detected. From an interpretation of their mass spectra, these compounds were identified as 17-hydroxymethyl metabolites, formed in vivo in the horse by oxidation of the 17-methyl moiety of 17α-methyltestosterone. This study reports on the GC/EI + MS identification of these novel 17-hydroxymethyl C20O3 and C20O4 metabolites of 17α-methyltestosterone excreted in thoroughbred horse urine. Copyright © 2003 John Wiley & Sons, Ltd.Keywords
This publication has 35 references indexed in Scilit:
- The metabolism of norethandrolone in the horse: characterization of 16‐, 20‐ and 21‐oxygenated metabolites by gas chromatography/mass spectrometryJournal of Mass Spectrometry, 2001
- Characterization of urinary metabolites of testosterone, methyltestosterone, mibolerone and boldenone in greyhound dogsJournal of Veterinary Pharmacology and Therapeutics, 2000
- Meloxicam: metabolic profile and biotransformation products in the ratXenobiotica, 1995
- Preliminary study of the metabolism of 17α-methyltestosterone in horses utilizing gas chromatography–mass spectrometric techniquesThe Analyst, 1994
- Identification of detomidine carboxylic acid as the major urinary metabolite of detomidine in the horseEuropean Journal of Drug Metabolism and Pharmacokinetics, 1992
- The use of stable isotopes and gas chromatography/mass spectrometry in the identification of steroid metabolites in the equineSteroids, 1990
- Detection of the administration of anabolic preparations of nandrolone to the entire male horseEquine Veterinary Journal, 1986
- Improved capillary gas-chromatographic-mass spectrometric method for the determination of anabolic steroid and corticosteroid metabolites in horse urine using on-column injection with high-boiling solventsThe Analyst, 1984
- Metabolism of 17α-methyltestosterone in the rabbit: C-6 and C-16 hydroxylated metabolitesSteroids, 1983
- Studies related to the metabolism of anabolic steroids in the horse: testosteroneXenobiotica, 1979